. "Cyclapen"@en . . . "Alburn, H.E., Grant, N.H. and Fletcher, H. Ill; US.Patent 3,194,802; assigned to American Home Products Corporation. Robinson, C.A. and Nescio, J.J.; US.Patent 3,478,018; November 11,1969; assigned to American Home Products Corporation."@en . . . . "(2S,5R,6R)-6-{[(1-aminocyclohexyl)carbonyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid"@en . "Ciclacilline"@en . . . . . . "Symptoms of overdose include severe diarrhea, nausea and vomiting."@en . "Bastcillin"@en . . . . . . . . "Moderately absorbed."@en . . . "6-(1-Aminocyclohexylcarboxamido)penicillanic acid"@en . . . . "Vipicil"@en . . . . . . "Vastcillin"@en . "Streptococcus pneumoniae"@en . . "Cyclacillin"@en . "A cyclohexylamido analog of penicillanic acid. [PubChem]"@en . "Cyclacillin"@en . "Calthor"@en . . "Aminocyclohexylpenicillin"@en . "Enteric bacteria and other eubacteria"@en . . "Wyvital"@en . . "Syngacillin"@en . "The bactericidal activity of cyclacillin results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs). Cyclacillin is stable in the presence of a variety of b-lactamases, including penicillinases and some cephalosporinases."@en . . "(1-Aminocyclohexyl)penicillin"@en . . "Citosarin"@en . "Ciclacillum"@en . . "approved"@en . "6-(1-Aminocyclohexanecarboxamido)penicillanic acid"@en . . . "Cyclapen-W"@en . "Ultracillin"@en . "Ciclacillinum"@en . . " "@en . "Ciclacillin"@en . . "For the treatment of bacterial infections caused by susceptible organisms."@en . "Haemophilus influenzae"@en . "3485-14-1"@en . . . . "Ciclacilina"@en .